e-learning
resources
Conferences
Respiratory Failure and Mechanical Ventilation Conference 2020
2020
Friday, 14.02.2020
Noninvasive ventilation (NIV) in COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
What are the targets?
M. Duiverman (Groningen, Netherlands)
Source:
Respiratory Failure and Mechanical Ventilation Conference 2020
Session:
Noninvasive ventilation (NIV) in COPD
Session type:
Symposium
Number:
80
Disease area:
Airway diseases, Respiratory critical care
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Duiverman (Groningen, Netherlands). What are the targets?. Respiratory Failure and Mechanical Ventilation Conference 2020
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
How to best target the hard-to-reach? The UK-experience?
Source: ERS Research Seminar 2018 – Lung Cancer Screening: from Trial to Practice
Year: 2018
Targeting targeted therapies: more choices and the best sequences
Source: International Congress 2018 – New drugs, strategies and research designs for advanced non-small cell lung cancer
Year: 2018
To tracheostomize or not to tracheostomize?
Source: Eur Respir J 2005; 26: Suppl. 49, 393s
Year: 2005
Lots of promising targets and biomarkers, but how can we deliver the next generation of severe asthma trials?
Source: International Congress 2019 – Beyond T2 mechanisms in asthma: who are the other players?
Year: 2019
MicroRNAs as future therapeutic targets in COPD?
Source: Eur Respir J, 49 (5) 1700431; 10.1183/13993003.00431-2017
Year: 2017
Advances in treatment of complex lung disease: will targeted therapy with anticalins be clinically applied in the near future?
Source: International Congress 2019 – Inhaled medicines and biological therapies in the current era of systemic treatments
Year: 2019
Targeted substances and no more?
Source: Annual Congress 2012 - Unimodal treatment for nonsmall cell lung cancer: dawn of a renaissance?
Year: 2012
TB following targeted and biological therapy: can we predict it?
Source: Virtual Congress 2020 – Tuberculosis and comorbidities
Year: 2020
Fibrocytes: potential new therapeutic targets for pulmonary hypertension?
Source: Eur Respir J 2010; 36: 1232-1235
Year: 2010
Immunotherapy: when, who and which drug?
Source: International Congress 2018 – New drugs, strategies and research designs for advanced non-small cell lung cancer
Year: 2018
New drugs for severe asthma – what should we target and how?
Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD
Year: 2014
Bringing it all together: common pathways, emerging therapeutics and future directions
Source: International Congress 2014 – From bench to bronchiole: translational immunology and airways disease
Year: 2014
From the bench: promising new targets and molecules
Source: International Congress 2016 – Scientific Year in Review 2016
Year: 2016
The new era of diagnostics: will it ever start?
Source: International Congress 2019 – Fighting antimicrobial resistance: from prevention to antimicrobial stewardship
Year: 2019
Targeted therapies for lung cancer: how did the game begin?
Source: Breathe 2016; 12: 177-179
Year: 2016
Rare pulmonary diseases and orphan drugs: where do we stand and where are we going to?
Source: Eur Respir Rev 2015; 24: 375-377
Year: 2015
The goal is to go further and do better: but how?
Source: Eur Respir Rev 2015; 25: 1-3
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept